Search

everythinglearnresearchcommunity

for

Search:↓

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Reductive stress messes up collagen balance and alters cell signaling in human skin cells, which could help treat certain skin diseases.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Protein hair straighteners damage the hair more than hair dyes.

Finasteride effectively treats frontal hair loss with few side effects.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Minoxidil not effective in preventing chemotherapy-induced hair loss.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Scalp involvement in pemphigus means the disease is more severe and harder to treat.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Low-dose oral minoxidil effectively improves male hair loss with mild side effects.

Knuckle Acanthosis Nigricans is common in Latin American youth and may indicate early insulin resistance, especially in those with normal weight.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Dr. Mario Lacouture recommends preventive and specific treatments for skin side effects caused by EGFR inhibitors to improve patients' quality of life.

Syphilitic alopecia, linked to syphilis and high-risk sexual behavior, improves with penicillin treatment.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Platelet-rich plasma may improve hair density and count in male pattern hair loss, but more high-quality research is needed.

QR678 Neo® improved seborrheic dermatitis symptoms in a small group of patients.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Low-level laser therapy effectively treats female hair loss, increasing hair count by 51%.

Women with high androgen levels may have more severe COVID-19 symptoms.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

COVID-19 may harm male fertility and damage the reproductive system.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.